FDA Investigator Regina Gibson Melton

Regina Gibson Melton has inspections in 1 countries as of 13 Sep 2023. Regina Gibson Melton has collaborated with a combinined 3060 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
92
Last Inspection Date:
13 Sep 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adams, Adriana N Jimenez Lopez, Amanda B Athey, Amber G Chung, Andrea Lwilliams Jones, Andrew J Howard, Angela L Hatzenbuhler, Ann Marie Montemurro, Annet R Rajan, Anthony F Lorenzo, Anthony W Lee, Arduino Frankovic, Austin B Appler, Barbara A Burke, Barbara A Gullick, Barbara J Holladay, Brooke K Higgins, Brooke K Secman, Bryan J Love, Burnell M Henry, Carole L Jones, Chaltu N Wakijra, Charlean R Butler, Charles D Boison, Charles E Idjagboro, Charles M Kerns, BLT DO, Christian D Lynch (CDL), Christopher R Richardson, Clarice J Ahn, David K Glasgow, David L Chon, David P Rice, Dawn M Collins, Denise R Beuttenmuller, Dennis L Doupnik, Derek S Smith, PhD, Deshonna L Mitchell, Diane T Bargo, Diane T O'bien, Diane T O'brien, Dianne H Milazzo, Douglas A Campbell, Dung N Tran, Edette J Newby, Edward P Potter, Eileen A Liu, Elvis D Morton, Emest F Bizjak, Emmanuel A Dimaano, Jr, Ephrem Hunde, PhD, Esaw, Gale L Glinecki, Gene D Arcy, Gerald B Seaborn, Jr, Heath A Gerber, Heath R Harley, Hector J Colon Torres, Helen B Ricalde, Holly S Simms, Hongna Wang, Hyesuk Kong, J David Doleski, Jacqueline Johnson, Jacquelyn D Hokamp, James L Kenney, DSc, James M Simpson, James T Mccoy, James W Leonette, Jamie D Richardson, Jamie D Swann, Janet A Rajan, Jeanne D Shaffer, Jeffrey A Reed, Jessica D Nanini, Jessica Hankins, PhD, John Dan, John M Gusto, John M Mcinnis, Johnson, Jonathan W Chapman, Joseph W Matthews, Jude C Dikes, Julie A Silberberg, Justin A Hefferman, Justin C Fuller, Karen A Spencer, Katherine M Williams, Kathleen M Jordan, Kelly L Anderson, Kenneth Nieves, La Tasha M Gunter, Lakisha M Williams, Latoya S Oliver Powell, Laurianne M Montonye, Laurissa S Flowers, LCDR Cornelius Brown, III, LCDR Debra Emerson, Linda J Eason, Lori S Lawless, LT Melanie M Mayor, USPHS, Malgorzata G Norton, Marc A Jackson, Jr, Marc S Neubauer, Margaret H Waters, Marion Michaelis, Matthew R Mcnew, Melissa J Garcia, Merideth K Rose, Michael D Omeara, Michael J Vardon, Michael L Zimmerman, Mildred L Mccray, Mohamad A Chahine, Monique Rac Lester, Myra L Gemmill, Nancy L Meade, Natasha A Dezinna, Nebil A Oumer, Nicholas A Violand, Nicholas P Schaub, Nicole K Trudel, Nina D Patel, Norman Fogg, Normica G Facey, Osama M Hamoud, Patricia A Morrow, Patrick C Klotzbuecher, Philip W Beck, Prabhu P Raju, Pratik S Upadhyay, DDC, Priscilla M Pastrana, Quyen T Tran, Rachel C Harrington, Randy F Pack, Regina G M, Renisha M Shaw, Rina Bhikha, Robert J Martin, Robert W Jennings, Rona A Leblanc, Ronald T Nowalk, Sean R Bryd, Sena G Dissmeyer, Shusheen A Alexander, Sidney B Priesmeyer, Slatten, State Agency, Steven P Donald, Susan J Essenmacher, Susan M Jackson, Suzanne M Healy, Sylvia R Dooling, Tamara N Champion, Tamika E Allen, RN, Tania E Vizcaino, Teresa L Fox, Theresa M Smedley, Thomas, Timothy M Albright, Toyin B Oladimeji, Troy C Quander, Valeria A Moore, Valerie G Vallely, Vesna V Stanoyevitch, Walter Fava, Walter L Fava, Wanda Y Fields, Wanda Y Honeyblue, Wayne L Jefferson, William A Warnick, William D Murray, William H Linkroum, Willy A Orantes

Regina Gibson Melton's Documents

Publish Date Document Type Title
February, 2002 EIR Union Memorial Hospital Bb - EIR, 2002-02-20
March, 2002 EIR Lonza Walkersville, Inc. - EIR, 2002-03-18
March, 2002 FDA 483 Response Cangene BioPharma, LLC - Form 483R, 2002-05-06
December, 2004 FDA 483 1257 Corporation - Form 483, 2004-12-03
March, 2002 EIR Cangene BioPharma, LLC - EIR, 2002-03-27
March, 2002 FDA 483 Cangene BioPharma, LLC - Form 483, 2002-03-27

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more